Immunotherapy in CRPC

Immunotherapy and Vaccines in Castration-resistant Prostate Cancer: What do we Know so far and Clinical Applications

Dr. James Gulley discusses immunotherapy for prostate cancer, including how therapeutic vaccines work, examples of therapeutic vaccines in mCRPC, appropriate patient populations to treat with immunotherapy, and immune checkpoint inhibitors.

James L. Gulley, MD, PhD, FACP - BIO
E-Newsletters

Newsletter subscription

Free Daily and Weekly newsletters offered by content of interest

The fields of GU Oncology and Urology are rapidly advancing. Sign up today for articles, videos, conference highlights and abstracts from peer-review publications by disease and condition delivered to your inbox and read on the go.

Subscribe